218 related articles for article (PubMed ID: 36646291)
1. Potassium channelopathies associated with epilepsy-related syndromes and directions for therapeutic intervention.
Gribkoff VK; Winquist RJ
Biochem Pharmacol; 2023 Feb; 208():115413. PubMed ID: 36646291
[TBL] [Abstract][Full Text] [Related]
2. BK channel properties correlate with neurobehavioral severity in three
Park SM; Roache CE; Iffland PH; Moldenhauer HJ; Matychak KK; Plante AE; Lieberman AG; Crino PB; Meredith A
Elife; 2022 Jul; 11():. PubMed ID: 35819138
[TBL] [Abstract][Full Text] [Related]
3. Channelopathies as a genetic cause of epilepsy.
Mulley JC; Scheffer IE; Petrou S; Berkovic SF
Curr Opin Neurol; 2003 Apr; 16(2):171-6. PubMed ID: 12644745
[TBL] [Abstract][Full Text] [Related]
4. The Functional Properties, Physiological Roles, Channelopathy and Pharmacological Characteristics of the Slack (KCNT1) Channel.
Zhang Q; Liu Y; Xu J; Teng Y; Zhang Z
Adv Exp Med Biol; 2021; 1349():387-400. PubMed ID: 35138624
[TBL] [Abstract][Full Text] [Related]
5. Molecular genetics of human familial epilepsy syndromes.
Hirose S; Okada M; Kaneko S; Mitsudome A
Epilepsia; 2002; 43 Suppl 9():21-5. PubMed ID: 12383275
[TBL] [Abstract][Full Text] [Related]
6. Neonatal Diabetes in Patients Affected by Liang-Wang Syndrome Carrying KCNMA1 Variant p.(Gly375Arg) Suggest a Potential Role of Ca
Mameli C; Cazzola R; Spaccini L; Calcaterra V; Macedoni M; La Verde PA; D'Auria E; Verduci E; Lista G; Zuccotti GV
Curr Issues Mol Biol; 2021 Aug; 43(2):1036-1042. PubMed ID: 34563042
[TBL] [Abstract][Full Text] [Related]
7.
Bailey CS; Moldenhauer HJ; Park SM; Keros S; Meredith AL
J Gen Physiol; 2019 Oct; 151(10):1173-1189. PubMed ID: 31427379
[No Abstract] [Full Text] [Related]
8. Neonatal epilepsy syndromes and GEFS+: mechanistic considerations.
Burgess DL
Epilepsia; 2005; 46 Suppl 10():51-8. PubMed ID: 16359473
[TBL] [Abstract][Full Text] [Related]
9. Functional Effects of Epilepsy Associated
Rychkov GY; Shaukat Z; Lim CX; Hussain R; Roberts BJ; Bonardi CM; Rubboli G; Meaney BF; Whitney R; Møller RS; Ricos MG; Dibbens LM
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499459
[TBL] [Abstract][Full Text] [Related]
10. BK Channelopathies and
Meredith AL
Annu Rev Physiol; 2024 Feb; 86():277-300. PubMed ID: 37906945
[TBL] [Abstract][Full Text] [Related]
11. KCNT1 epilepsy with migrating focal seizures shows a temporal sequence with poor outcome, high mortality and SUDEP.
Kuchenbuch M; Barcia G; Chemaly N; Carme E; Roubertie A; Gibaud M; Van Bogaert P; de Saint Martin A; Hirsch E; Dubois F; Sarret C; Nguyen The Tich S; Laroche C; des Portes V; Billette de Villemeur T; Barthez MA; Auvin S; Bahi-Buisson N; Desguerre I; Kaminska A; Benquet P; Nabbout R
Brain; 2019 Oct; 142(10):2996-3008. PubMed ID: 31532509
[TBL] [Abstract][Full Text] [Related]
12. Two Patients With KCNT1-Related Epilepsy Responding to Phenobarbital and Potassium Bromide.
Datta AN; Michoulas A; Guella I; ; Demos M
J Child Neurol; 2019 Oct; 34(12):728-734. PubMed ID: 31208268
[No Abstract] [Full Text] [Related]
13. An emerging spectrum of variants and clinical features in
Miller JP; Moldenhauer HJ; Keros S; Meredith AL
Channels (Austin); 2021 Dec; 15(1):447-464. PubMed ID: 34224328
[No Abstract] [Full Text] [Related]
14. KCNT1-related epilepsies and epileptic encephalopathies: phenotypic and mutational spectrum.
Bonardi CM; Heyne HO; Fiannacca M; Fitzgerald MP; Gardella E; Gunning B; Olofsson K; Lesca G; Verbeek N; Stamberger H; Striano P; Zara F; Mancardi MM; Nava C; Syrbe S; Buono S; Baulac S; Coppola A; Weckhuysen S; Schoonjans AS; Ceulemans B; Sarret C; Baumgartner T; Muhle H; Portes VD; Toulouse J; Nougues MC; Rossi M; Demarquay G; Ville D; Hirsch E; Maurey H; Willems M; de Bellescize J; Altuzarra CD; Villeneuve N; Bartolomei F; Picard F; Hornemann F; Koolen DA; Kroes HY; Reale C; Fenger CD; Tan WH; Dibbens L; Bearden DR; Møller RS; Rubboli G
Brain; 2021 Dec; 144(12):3635-3650. PubMed ID: 34114611
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and biological evaluation of a novel series of 1,2,4-oxadiazole inhibitors of SLACK potassium channels: Identification of in vitro tool VU0935685.
Qunies AM; Spitznagel BD; Du Y; David Weaver C; Emmitte KA
Bioorg Med Chem; 2023 Nov; 95():117487. PubMed ID: 37812884
[TBL] [Abstract][Full Text] [Related]
16. [Potassium channelopathies and Morvan's syndromes].
Serratrice G; Pellissier JF; Serra-Trice J; Weiller PJ
Bull Acad Natl Med; 2010 Feb; 194(2):391-406; discussion 406-7. PubMed ID: 21166127
[TBL] [Abstract][Full Text] [Related]
17. Genetic testing in benign familial epilepsies of the first year of life: clinical and diagnostic significance.
Zara F; Specchio N; Striano P; Robbiano A; Gennaro E; Paravidino R; Vanni N; Beccaria F; Capovilla G; Bianchi A; Caffi L; Cardilli V; Darra F; Bernardina BD; Fusco L; Gaggero R; Giordano L; Guerrini R; Incorpora G; Mastrangelo M; Spaccini L; Laverda AM; Vecchi M; Vanadia F; Veggiotti P; Viri M; Occhi G; Budetta M; Taglialatela M; Coviello DA; Vigevano F; Minetti C
Epilepsia; 2013 Mar; 54(3):425-36. PubMed ID: 23360469
[TBL] [Abstract][Full Text] [Related]
18. Neonatal seizures and long QT syndrome: a cardiocerebral channelopathy?
Heron SE; Hernandez M; Edwards C; Edkins E; Jansen FE; Scheffer IE; Berkovic SF; Mulley JC
Epilepsia; 2010 Feb; 51(2):293-6. PubMed ID: 19863579
[TBL] [Abstract][Full Text] [Related]
19. In silico model reveals the key role of GABA in KCNT1-epilepsy in infancy with migrating focal seizures.
Kuchenbuch M; Nabbout R; Yochum M; Sauleau P; Modolo J; Wendling F; Benquet P
Epilepsia; 2021 Mar; 62(3):683-697. PubMed ID: 33617692
[TBL] [Abstract][Full Text] [Related]
20. The Phe932Ile mutation in KCNT1 channels associated with severe epilepsy, delayed myelination and leukoencephalopathy produces a loss-of-function channel phenotype.
Evely KM; Pryce KD; Bhattacharjee A
Neuroscience; 2017 May; 351():65-70. PubMed ID: 28366665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
